VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $227,000 | -73.8% | 1,150 | -81.0% | 0.32% | -54.0% |
| Q4 2014 | $866,000 | -0.6% | 6,050 | -9.0% | 0.70% | +4.0% |
| Q3 2014 | $871,000 | +3.6% | 6,650 | 0.0% | 0.67% | +16.3% |
| Q2 2014 | $841,000 | -59.8% | 6,650 | -58.2% | 0.58% | -49.6% |
| Q1 2014 | $2,093,000 | -49.6% | 15,900 | -55.1% | 1.14% | -30.5% |
| Q4 2013 | $4,153,000 | -53.8% | 35,400 | -58.9% | 1.64% | +33.6% |
| Q3 2013 | $8,980,000 | +33.7% | 86,200 | +10.7% | 1.23% | +42.0% |
| Q2 2013 | $6,715,000 | – | 77,900 | – | 0.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |